BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20128972)

  • 21. Changes in liver biochemical tests at diagnosis and after propylthiouracil therapy for hyperthyroidism.
    Gürlek A; Cobankara V; Bayraktar M
    Mater Med Pol; 1996; 28(3):103-6. PubMed ID: 9167420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of maternal hyperthyroidism and antithyroid drug therapy on congenital malformation of newborn infants].
    Lian XL; Bai Y; Xu YH; Dai WX; Guo ZS
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):511-5. PubMed ID: 16202286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
    Dai W; Zhang J; Zhan Z; Xu B; Jin H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
    Karras S; Tzotzas T; Kaltsas T; Krassas GE
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):25-33. PubMed ID: 21037541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole.
    Mujtaba Q; Burrow GN
    Obstet Gynecol; 1975 Sep; 46(3):282-6. PubMed ID: 51489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Side effects of antithyroid therapy of hyperthyroidism. A study of 1256 continuously treated patients].
    Meyer-Gessner M; Benker G; Olbricht T; Windeck R; Cissewski K; Reiners C; Reinwein D
    Dtsch Med Wochenschr; 1989 Feb; 114(5):166-71. PubMed ID: 2464468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dosage problems in initial thyreostatic therapy of diffuse hyperthyreosis with methylmercaptoimidazole].
    Morgner KD; Gillich KH; Krüskemper HL; Zeidler U
    Med Klin; 1973 Aug; 68(32):1038-41. PubMed ID: 4126297
    [No Abstract]   [Full Text] [Related]  

  • 28. The safety and efficacy of antithyroid drugs.
    Azizi F
    Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid suppression test as index of outcome of hyperthyroidism treated with antithyroid drugs.
    Cassidy CE
    Metabolism; 1970 Oct; 19(10):745-50. PubMed ID: 4096944
    [No Abstract]   [Full Text] [Related]  

  • 30. Twin pregnancy with a coexisting hydatiform mole and liveborn infant: complicated by maternal hyperthyroidism and neonatal hypothyroidism.
    True DK; Thomsett M; Liley H; Chitturi S; Cincotta R; Morton A; Cotterill A
    J Paediatr Child Health; 2007 Sep; 43(9):646-8. PubMed ID: 17688651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rare side effects in management of hyperthyroidism. Case report].
    Sohár G; Kovács M; Györkös A; Gasztonyi B
    Orv Hetil; 2016 May; 157(22):869-72. PubMed ID: 27211356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperthyroidism associated with pregnancy.
    Goluboff LG; Sisson JC; Hamburger JI
    Obstet Gynecol; 1974 Jul; 44(1):107-16. PubMed ID: 4134902
    [No Abstract]   [Full Text] [Related]  

  • 33. Thyrotoxic periodic paralysis.
    Resnick JS; Dorman JD; Engel WK
    Am J Med; 1969 Nov; 47(5):831-6. PubMed ID: 4187471
    [No Abstract]   [Full Text] [Related]  

  • 34. [Thyrostatic treatment and its adverse effects].
    Dokupilová A; Payer J
    Vnitr Lek; 2013 Nov; 59(11):989-95. PubMed ID: 24279443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe pancytopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure.
    Macia M; Méndez M; Fernández J; Riverol A; Rios
    Clin Nephrol; 1997 Feb; 47(2):129. PubMed ID: 9049463
    [No Abstract]   [Full Text] [Related]  

  • 36. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies.
    Cooper DS
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3474-81. PubMed ID: 12915620
    [No Abstract]   [Full Text] [Related]  

  • 37. Confluent and reticulated papillomatosis associated with hyperthyroidism.
    Zhang CH; Zhang C; Wu J; Shan SJ; Liu QZ; Fu Z; Guo Y; Wei H; Chen HD
    Eur J Dermatol; 2010; 20(6):833-5. PubMed ID: 20937587
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologic management of feline hyperthyroidism.
    Trepanier LA
    Vet Clin North Am Small Anim Pract; 2007 Jul; 37(4):775-88, vii. PubMed ID: 17619011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical treatment of hyperthyroidism: state of the art.
    Fumarola A; Di Fiore A; Dainelli M; Grani G; Calvanese A
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):678-84. PubMed ID: 20496313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
    Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
    Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.